11-74277002-G-T
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM1PM2PP3_Strong
The NM_182904.5(P4HA3):c.1318C>A(p.His440Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,613,570 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_182904.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
P4HA3 | NM_182904.5 | c.1318C>A | p.His440Asn | missense_variant | 9/13 | ENST00000331597.9 | NP_878907.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
P4HA3 | ENST00000331597.9 | c.1318C>A | p.His440Asn | missense_variant | 9/13 | 1 | NM_182904.5 | ENSP00000332170.4 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152176Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250208Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135158
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1461394Hom.: 0 Cov.: 30 AF XY: 0.0000124 AC XY: 9AN XY: 726948
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152176Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74334
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2024 | The c.1318C>A (p.H440N) alteration is located in exon 9 (coding exon 9) of the P4HA3 gene. This alteration results from a C to A substitution at nucleotide position 1318, causing the histidine (H) at amino acid position 440 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at